Nonrandom occurrence of lymphoid cancer types in 140 families

References

• The American Cancer Society. Cancer facts & figures 2014. Atlanta, GA: The American Cancer Society; 2014.
   Google Scholar
• Swerdlow S, Campo E, Harris N, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008.
   Google Scholar
• Grufferman S, Barton J, Eby N. Increased sex concordance of sibling pairs with Behçet's disease, Hodgkin's disease, multiple sclerosis, and sarcoidosis. Am J Epidemiol. 1987;126:365–369.
   PubMed Web of Science ®Google Scholar
• Chatterjee N, Hartge P, Cerhan JR, et al. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev. 2004;13:1415–1421.
   PubMed Web of Science ®Google Scholar
• Lan Q, Zheng T, Chanock S, et al. Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis. 2007;28:823–827.
   PubMed Web of Science ®Google Scholar
• Crump C, Sundquist K, Sieh W, et al. Perinatal and family risk factors for non-Hodgkin lymphoma in early life: a Swedish national cohort study. J Natl Cancer Inst. 2012;104:923–930.
   PubMedGoogle Scholar
• Paltiel O, Schmit T, Adler B, et al. The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: Results and limitations of a registry-linked study. Cancer. 2000;88:2357–2366.
   PubMed Web of Science ®Google Scholar
• Goldin LR, Pfeiffer RM, Gridley G, et al. Familial aggregation of Hodgkin lymphoma and related tumors. Cancer. 2004;100:1902–1908.
   PubMed Web of Science ®Google Scholar
• Goldin LR, Pfeiffer RM, Li X, et al. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood. 2004;104:1850–1855.
   PubMed Web of Science ®Google Scholar
• Goldin LR, Björkholm M, Kristinsson SY, et al. Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia. Haematologica. 2009;94:647–653.
   PubMed Web of Science ®Google Scholar
• Goldin LR, Landgren O, McMaster ML, et al. Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples. Cancer Epidemiol Biomarkers Prev. 2005;14:2402–2406.
   PubMed Web of Science ®Google Scholar
• Chang ET, Smedby KE, Hjalgrim H, et al. Family history of hematopoietic malignancy and risk of lymphoma. J Natl Cancer Inst. 2005;97:1466–1474.
   PubMed Web of Science ®Google Scholar
• Frank C, Fallah M, Chen T, et al. Search for familial clustering of multiple myeloma with any cancer. Leukemia. 2016;30:627–632.
   PubMed Web of Science ®Google Scholar
• Landgren O, Kristinsson SY, Goldin LR, et al. Risk of plasma cell and lymphoproliferative disorders among 14 621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden. Blood. 2009;114:791–796.
   PubMed Web of Science ®Google Scholar
• Altieri A, Chen B, Bermejo JL, et al. Familial risks and temporal incidence trends of multiple myeloma. Europ J Cancer (Oxford, England: 1990). 2006;42:1661–1670.
   PubMed Web of Science ®Google Scholar
• Fallah M, Kharazmi E, Pukkala E, et al. Familial risk of non-Hodgkin lymphoma by sex, relationship, age at diagnosis and histology: a joint study from five Nordic countries. Leukemia. 2016;30:373–378.
   PubMed Web of Science ®Google Scholar
• Alexander DD, Mink PJ, Adami H-O, et al. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer. 2007;120:1–39.
   PubMed Web of Science ®Google Scholar
• Bernstein L, Ross RK. Prior medication use and health history as risk factors for non-Hodgkin’s lymphoma: preliminary results from a case-control study in Los Angeles County. Cancer Res. 1992;52:5510s–5516s.
   PubMed Web of Science ®Google Scholar
• Alexandrescu DT, Garino A, Brown-Balem KA, et al. Anticipation in families with Hodgkin’s and non-Hodgkin’s lymphoma in their pedigree. Leuk Lymphoma. 2006;47:2115–2127.
   PubMed Web of Science ®Google Scholar
• Kharazmi E, Fallah M, Pukkala E, et al. Risk of familial classical Hodgkin lymphoma by relationship, histology, age, and sex: a joint study from five Nordic countries. Blood. 2015;126:1990–1995.
   PubMed Web of Science ®Google Scholar
• Lindqvist EK, Goldin LR, Landgren O, et al. Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study. Blood. 2011;118:6284–6292.
   PubMed Web of Science ®Google Scholar
• Slager SL, Rabe KG, Achenbach SJ, et al. Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood. 2011;117:1911–1917.
   PubMed Web of Science ®Google Scholar
• Wiernik PH, Wickramasinghe D, Dutcher JP. Families with both Hodgkin lymphoma and multiple myeloma in their pedigrees. Clin Adv Hematol Oncol. 2015;13:257–260.
   PubMed Web of Science ®Google Scholar
• Sud A, Mitchell J, Cooke R, et al. A genomic approach to estimating the heritability of Hodgkin lymphoma. Clin Lymphoma Myeloma Leukemia. 2015;15:S39–S40.
   Google Scholar
• Thomsen H, da Silva Filho MI, Försti A, et al. Heritability estimates on Hodgkin’s lymphoma: a genomic- versus population-based approach. Europ J Human Genet. 2014;23:824–830.
   PubMed Web of Science ®Google Scholar
• Sampson JN, Wheeler WA, Yeager M, et al. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types. JNCIJ. 2015;107:279.
   Web of Science ®Google Scholar
• Berndt SI, Skibola CF, Joseph V, et al. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet. 2013;45:868–876.
   PubMed Web of Science ®Google Scholar
• Di Bernardo MC, Broderick P, Catovsky D, et al. Common genetic variation contributes significantly to the risk of developing chronic lymphocytic leukemia. Haematologica. 2013;98:23–24.
   PubMedGoogle Scholar
• Mitchell JS, Johnson DC, Litchfield K, et al. Implementation of genome-wide complex trait analysis to quantify the heritability in multiple myeloma. Sci Rep. 2015;5:12473.
   PubMed Web of Science ®Google Scholar
• Cerhan JR, Berndt SI, Vijai J, et al. Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. Nat Genet. 2014;46:1233–1236.
   PubMed Web of Science ®Google Scholar
• Tegg EM, Thomson RJ, Stankovich J, et al. Evidence for a common genetic aetiology in high-risk families with multiple haematological malignancy subtypes. Br J Haematol. 2010;150:456–462.
   PubMed Web of Science ®Google Scholar
• Küppers R. Mechanisms of B-cell lymphoma pathogenesis. Nature reviews. Nat Rev Cancer. 2005;5:251–262.
   PubMed Web of Science ®Google Scholar
• Bassig BA, Lan Q, Rothman N, et al. Current understanding of lifestyle and environmental factors and risk of non-Hodgkin lymphoma: an epidemiological update. J Cancer Epidemiol. 2012;2012:Article ID 978930. doi: 10.1155/2012/978930
   PubMedGoogle Scholar
• Ekstro K, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008;111:4029–4038.
   PubMed Web of Science ®Google Scholar
• Anderson LA, Gadalla S, Morton LM, et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer. 2009;125:398–405.
   PubMed Web of Science ®Google Scholar
• Zintzaras E, Voulgarelis M, Moutsopoulos H. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005;165:2337–2344.
   PubMed Web of Science ®Google Scholar
• Maggioncalda A, Malik N, Shenoy P, et al. Clinical, molecular, and environmental risk factors for Hodgkin Lymphoma. Adv Hematol. 2010;2011:Article ID 736261. doi: 10.1155/2011/736261
   Google Scholar
• Boffetta P. I. Epidemiology of adult non-Hodgkin lymphoma. Ann Oncol. 2011;22:iv27–iv31.
   Web of Science ®Google Scholar
• Enciso-Mora V, Broderick P, Ma Y, et al. A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3) ). Nat Genet. 2010;42:1126–1130.
   PubMed Web of Science ®Google Scholar
• Skibola CF, Berndt SI, Vijai J, et al. Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region. Am J Hum Genet. 2014;95:462–471.
   PubMed Web of Science ®Google Scholar
• Rendleman J, Antipin Y, Reva B, et al. Genetic variation in DNA repair pathways and risk of non-Hodgkin's lymphoma. PLoS One. 2014;9:e101685
   PubMed Web of Science ®Google Scholar
• Salipante SJ, Mealiffe ME, Wechsler J, et al. Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells. Proc Nat Acad Sci. 2009;106:14920–14925.
   PubMed Web of Science ®Google Scholar
• Rotunno M, McMaster ML, Boland J, et al. Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene. Haematologica. 2016;853–860.
   PubMed Web of Science ®Google Scholar
• Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286:1957–1960.
   PubMed Web of Science ®Google Scholar
• Clementi R, Emmi L, Maccario R, et al. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood. 2002;100:2266–2268.
   PubMed Web of Science ®Google Scholar
• Clementi R, Locatelli F, Garaventa A, et al. A proportion of patients with lymphoma may harbor mutations of the perforin gene. Blood. 2005;105:4424–4429.
   PubMed Web of Science ®Google Scholar
• Clementi R, Dagna L, Dianzani U, et al. Inherited perforin and Fas mutations in a patient with Autoimmune Lymphoproliferative Syndrome and Lymphoma. N Engl J Med. 2004;351:1419–1424.
   PubMed Web of Science ®Google Scholar
• Wiernik P, Wang S, Hu X-P, et al. Age of onset evidence for anticipation in familial non-Hodgkin’s lymphoma. Br J Haematol. 2000;108:72–79.
   PubMed Web of Science ®Google Scholar
• Shugart YY, Hemminki K, Vaittinen P, et al. A genetic study of Hodgkin's lymphoma: an estimate of heritability and anticipation based on the familial cancer database in Sweden. Hum Genet. 2000;106:553–556.
   PubMed Web of Science ®Google Scholar
• Wiernik PH, Ashwin M, Hu X, Paietta E, Brown K. Anticipation in familial chronic lymphocytic leukaemia. Br J Haematol. 2001;113:407–414.
   PubMed Web of Science ®Google Scholar
• Auer RL, Dighiero G, Goldin LR, et al. Trinucleotide repeat dynamic mutation identifying susceptibility in familial and sporadic chronic lymphocytic leukaemia. Br J Haematol. 2007;136:73–79.
   PubMed Web of Science ®Google Scholar
• Awan H, Jønsson V, Johannesen TB, et al. Anticipation in families with chronic lymphocytic leukemia and other lymphoproliferative disorders. Transl Oncogenomics. 2010;4:1–9.
   PubMedGoogle Scholar
• Lynch HT, Watson P, Tarantolo S, et al. Phenotypic heterogeneity in multiple myeloma families. J Clin Oncol. 2005;23:685–693.
   PubMed Web of Science ®Google Scholar
• Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database [Internet]: Incidence – SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2014 Sub (1973–2012) – National Cancer Institute, Surveillance Research Program. 2014. Available from: http://www.seer.cancer.gov/.
   Google Scholar
• Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database [Internet]: Incidence – SEER 13 Regs Research Data, Nov 2014 Sub (1992–2012) – National Cancer Institute, Surveillance Research Program. 2014. Available from: http://www.seer.cancer.gov/.
   Google Scholar
• Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence – SEER 9 Regs Research Data, Nov 2014 Sub (1973–2012) – National Cancer Institute, Surveillance Research Program. 2014. Available from: http://www.seer.cancer.gov/.
   Google Scholar
• Surveillance Research Program, National Cancer Institute SEER*Stat software, Version 8.2.1.
   Google Scholar
• Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review 1975?2011. Bethesda, MD: National Cancer Institute; 2011:12–15.
   Google Scholar
• Shugart YY, Hemminki K, Vaittinen P, et al. Apparent anticipation and heterogeneous transmission patterns in familial Hodgkin's and non-Hodgkin's lymphoma: report from a study based on Swedish cancer database. Leuk Lymphoma. 2001;42:407–415.
   PubMed Web of Science ®Google Scholar
• Ashley CT, Warren ST. Trinucleotide repeat expansion and human disease. Annu Rev Genet. 1995;29:703–728.
   PubMed Web of Science ®Google Scholar
• Thomas RK, Re D, Zander T, et al. Epidemiology and etiology of Hodgkin’s lymphoma. Ann Oncol. 2002;13:147–152.
   PubMed Web of Science ®Google Scholar
• Cartwright RA, Watkins G. Epidemiology of Hodgkin’s disease: a review. Hematol Oncol. 2004;22:11–26.
   PubMed Web of Science ®Google Scholar